How depressive symptoms correlate with stigma perception of mental illness

Freidl, Marion; Spitzl, S Piralic; Aigner, Martin

doi:10.1080/09540260802565422

Cited by 26 publications

(20 citation statements)

References 27 publications

Supporting

Mentioning

Contrasting

Unclassified

Order By: Relevance

“…The severity of depressive symptoms was the strongest correlate of stigma toward mental illness, which accounted for 14% additional variance above and beyond the variance accounted for by all other variables. This result is consistent with the finding of a previous literature that high level of perceived stigma toward mental illness is associated with severity of depressive symptoms in patients . To our knowledge, this is the first study conducted in Jordan to assess the level of stigma toward mental illness and factors associated with stigma toward mental illness among Jordanian patients diagnosed with MDD.…”

Section: Discussionsupporting

confidence: 92%

The correlates of stigma toward mental illness among Jordanian patients with major depressive disorder

Rayan

Mahroum

Khasawneh

2017

Perspect Psychiatr Care

View full text Add to dashboard Cite

show abstract

Section: Discussionsupporting

confidence: 92%

The correlates of stigma toward mental illness among Jordanian patients with major depressive disorder

Rayan

Mahroum

Khasawneh

2017

Perspect Psychiatr Care

View full text Add to dashboard Cite

show abstract

“…From an epidemiological perspective, it is now well established that most psychiatric patients – for several reasons – often experience many years of illness before beginning adequate pharmacological treatment, receiving a correct diagnosis, or even before consulting a clinician [15,16,17]. This is partly due to the secretiveness and social stigma that characterize many mental disorders [18], as well as to the lack of insight which is characteristic, at some point of the illness, of major psychoses (e.g.…”

Section: Resultsmentioning

confidence: 99%

Can Long-Term Outcomes Be Improved by Shortening the Duration of Untreated Illness in Psychiatric Disorders? A Conceptual Framework

et al. 2012

View full text Add to dashboard Cite

The duration of untreated illness (DUI), meaning the latency to the pharmacological treatment, has been increasingly investigated in the last decade as a predictor of outcome across different psychiatric conditions, particularly in psychotic disorders. DUI is essentially computed by subtracting the age of onset of a specific disorder from the age at which the first adequate pharmacological treatment is administered. Assessment of the latency to treatment represents one of the first steps in planning early interventions. This review examines the role of the DUI in psychotic and affective disorders, focusing on neuropathological, epidemiologic, clinical and prognostic factors related to a longer latency to treatment. Through a Medline and Cochrane Library search, relevant studies up to June 2011 and other pertinent articles including meta-analyses, randomized controlled trials, naturalistic studies and clinical reviews were identified. Converging evidence indicates that a prolonged DUI negatively influences the outcome of first-episode psychosis and schizophrenia in different ways, and increasing data point toward a similar conclusion in affective disorders. Even though methodological limitations related to investigation of the DUI need to be considered, research and interventions aimed to reduce latency to treatments are object of increasing implementation worldwide. The assessment of the DUI represents one of the most important parameters to consider in this perspective, in order to quantify different latency to treatment in specific disorders and to plan related, targeted interventions.

show abstract

“…In fact, it is well established that psychiatric patients -for several reasons -often wait for many years before beginning a proper pharmacological treatment, before receiving a correct diagnosis or even before consulting a clinician (Kohn et al, 2004). This is certainly due -at least in partto the secretiveness and social stigma that characterize some forms of mental disorders (Freidl et al, 2008) as well as to the lack of insight, which is characteristic of major psychoses [i.e. schizophrenia and bipolar disorder (BD)].…”

Section: Introductionmentioning

confidence: 99%

Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study

Altamura

Buoli

Albano

et al. 2010

International Clinical Psychopharmacology

113

View full text Add to dashboard Cite

This study was designed to investigate and compare demographic and clinical features with specific emphasis on age at onset, age at first treatment and, in particular, on duration of untreated illness (DUI), in patients with different mood and anxiety disorders. Study sample included 729 outpatients with the following diagnoses: major depressive disorder (n=181), bipolar disorder type I (BD I, n=115) and II (BD II, n=186), generalized anxiety disorder (n=100), panic disorder (n=96), and obsessive-compulsive disorder (n=51). Main demographic and clinical variables of the sample were compared among the diagnostic groups using one-way analysis of variance or chi tests. The diagnostic groups showed significant differences in relation to age at onset and age at first pharmacological treatment and in relation to latency to treatment. In particular, patients with major depressive disorder showed the shortest DUI (39.08 months), whereas patient with BD II showed the longest DUI (97.2 months) in comparison with the other groups. Within the group with anxiety disorders (F=7.512, P<0.001), patients with panic disorder showed the shortest DUI (44.35 months), whereas patients with obsessive-compulsive disorder showed the longest DUI (90.57 months). The present findings suggest that patients with different mood and anxiety disorders show significant differences in terms of age at onset, age at first treatment and, consequently, DUI, which potentially reflect different reasons influencing treatment delay.

show abstract

How depressive symptoms correlate with stigma perception of mental illness

Cited by 26 publications

References 27 publications

The correlates of stigma toward mental illness among Jordanian patients with major depressive disorder

The correlates of stigma toward mental illness among Jordanian patients with major depressive disorder

Can Long-Term Outcomes Be Improved by Shortening the Duration of Untreated Illness in Psychiatric Disorders? A Conceptual Framework

Age at onset and latency to treatment (duration of untreated illness) in patients with mood and anxiety disorders: a naturalistic study

Contact Info

Product

Resources

About